1. FOLLICULAR LYMPHOMA: PRE‐TREATMENT TEP/CT SCAN TEXTURE PARAMETERS AS PREDICTIVE BIOMARKERS OF PROGRESSION FREE SURVIVAL AND TIME TO NEXT TREATMENT. (12th June 2019) Authors: Durot, E.; Mulé, S.; Morland, D.; Jolly, D.; Delmer, A.; Hoeffel, C.; Durot, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BONE MARROW INVOLVEMENT, BUT NO BLOOD INVOLVEMENT, IMPAIRS SURVIVAL IN ANGIOIMMUNOBLASTIC T CELL LYMPHOMA: AN ANCILLARY STUDY OF THE REVAIL TRIAL. (12th June 2019) Authors: Lemonnier, F.; Safar, V.; Ferchiou, A.; Cottereau, A.; Bachy, E.; Cartron, G.; Moles‐Moreau, M.; Delmer, A.; Bouabdallah, R.; Voillat, L.; Parrens, M.; Casasnovas, O.; Cacheux, V.; Réguy, C.; Tilly, H.; Meignan, M.; Gaulard, P.; de Leval, L.; Delfau‐Larrue, M.; Haioun, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FIRST‐LINE THERAPY OF T‐CELL LYMPHOMA: ALLOGENEIC OR AUTOLOGOUS TRANSPLANTATION FOR CONSOLIDATION ‐ FINAL RESULTS OF THE AATT STUDY. (12th June 2019) Authors: Tournilhac, O.; Truemper, L.; Ziepert, M.; Bouabdallah, K.; Nickelsen, M.; Maury, S.; Reimer, P.; Jaccard, A.; Herr, W.; Wilhelm, M.; Cartron, G.; Wulf, G.; Sanhes, L.; Dreger, P.; Lamy, T.; Kroschinsky, F.; Lindemann, H.; Roussel, M.; Viardot, A.; Sibon, D. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A PROGNOSTIC SCORE FOR TRANSFORMED WALDENSTRÖM MACROGLOBULINEMIA. (12th June 2019) Authors: Durot, E.; Kanagaratnam, L.; D'sa, S.; Tomowiak, C.; Hivert, B.; Toussaint, E.; Guerrero‐Garcia, T.; Itchaki, G.; Vos, J.; Michallet, A.; Godet, S.; Bomsztyk, J.; Morel, P.; Leblond, V.; Treon, S.P.; Delmer, A.; Castillo, J.J. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. INTEGRATIVE ANALYSIS OF FEATURES ASSOCIATED WITH TET2, IDH2, DNMT3A, AND RHOA MUTATIONS IN ANGIOIMMUNOBLASTIC T CELL LYMPHOMA: A LYSA STUDY. (June 2017) Authors: Lemonnier, F.; Safar, V.; Cottereau, A.; Fataccioli, V.; Chaillol, I.; Pelletier, R.; Letourneau, A.; Dupuy, A.; Bossard, C.; Martin, A.; Robe, C.; Pelletier, L.; Pujals, A.; Bachy, E.; Delmer, A.; Moles Moreau, M.; Tilly, H.; Parrens, M.; Delfau‐Larue, M.; Missiaglia, E. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA. (23rd June 2022) Authors: Zanwar, S.; Abeykoon, J.; Castillo, J.; Durot, E.; Kastritis, E.; Uppal, E.; Morel, P.; Tawfiq, R.; Montes, L.; Paludo, J.; Sarosiek, S.; Kumar, S.; Ogunbiyi, O.; Cornillet-Lefebvre, P.; Kyle, R.; Delmer, A.; Gertz, M.; Dimopoulos, M.; Ansell, S.; Treon, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1046 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P672: REAL-LIFE EFFICACY AND SAFETY OF VENETOCLAX MONOTHERAPY IN RELAPSED/ REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA - INTERIM ANALYSIS OF MULTICENTRIC STUDY VERONE. (23rd June 2022) Authors: Ysebaert, L.; Troussard, X.; Levy, V.; Le Calloch, R.; Guieze, R.; Leprêtre, S.; Michallet, A.-S.; Leblond, V.; Feugier, P.; Ramier, J.; Delmer, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 570 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. One-day prevalence of asymptomatic carriage of toxigenic and non-toxigenic Clostridioides difficile in 10 French hospitals. (November 2022) Authors: Le Monnier, A.; Candela, T.; Mizrahi, A.; Bille, E.; Bourgeois-Nicolaos, N.; Cattoir, V.; Farfour, E.; Grall, I.; Lecointe, D.; Limelette, A.; Marcade, G.; Poilane, I.; Poupy, P.; Kansau, I.; Zahar, J-R.; Pilmis, B.; Hartmann, C.; Kazhalawi, A.; Lambert-Bordes, S.; Bleunven, S. Journal: Journal of hospital infection Issue: Volume 129(2022) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 15 HLA-MATCHED ALLOGENEIC STEM CELL TRANSPLANTATION IMPROVES OVERALL SURVIVAL OF HIGHER RISK MYELODYSPLASTIC SYNDROME. (April 2015) Authors: Robin, M.; Porcher, R.; Ades, L.; Raffoux, E.; Michallet, M.; François, S.; Cahn, J.Y.; Delmer, A.; Wattel, E.; Vigouroux, S.; Bay, J.O.; Cornillon, J.; Huynh, A.; Nguyen, S.; Rubio, M.T.; Vincent, L.; Maillard, N.; Charbonnier, A.; de Latour, R. Peffault; Oumedaly, R. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗